The drug semaglutide and its contemporaries, often referred colloquially by patients as "ozempic", represents a massive sea change in weight loss management. So we wanted to ask our physicians what they think of these SLG-1RAs, both the benefits and challenges. So we did a survey, and some of the data is quite eye-opening. If you're interested in these drugs and what physicians think about them, check out our full survey results here: https://lnkd.in/gQwYR5xv
